Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.

We studied 374 women taking oral contraceptives, 284 women taking estrogen preparations after menopause, and 1086 women taking no hormones, to determine the relation of plasma lipids and lipoprotein cholesterol concentrations to various types of estrogen/progestin formulations. Premenopausal women, using oral contraceptives containing a relatively low dose of estrogen combined with a medium or high dose of progestin (Norlestrin, Ovral, or Demulen) had a 24 per cent higher median concentration of low-density-lipoprotein cholesterol than did those not using hormones (P less than 0.05). Women using oral contraceptives that are high in estrogen and low in progestin (Enovid or Oracon) had significantly higher concentrations of high-density-lipoprotein cholesterol than did nonusers; those using Ovral, a low-estrogen and high-progestin formulation, had significantly lower levels of high-density-lipoprotein cholesterol. In postmenopausal women the use of estrogen was associated with concentrations of low-density-lipoprotein cholesterol that were 11 to 19 per cent below the levels in postmenopausal women who did not use hormones. The effects of estrogen-progestin balance on low-density and high-density lipoproteins may underlie the increased incidence of stroke and myocardial infarction in women of childbearing age who take oral contraceptives.

[1]  P. Wahl,et al.  Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. , 1981, The Journal of clinical endocrinology and metabolism.

[2]  B. Stadel Oral contraceptives and cardiovascular disease (first of two parts). , 1981, The New England journal of medicine.

[3]  S. Shapiro,et al.  Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. , 1981, The New England journal of medicine.

[4]  W. Willett,et al.  Use of Postmenopausal Hormones and Risk of Myocardial Infarction , 1981, Circulation.

[5]  V. Manninen,et al.  Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement Therapy , 1981 .

[6]  P. Wilson,et al.  Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. , 1980, The American journal of cardiology.

[7]  S. Thompson,et al.  Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. , 1980, British medical journal.

[8]  D. Jacobs,et al.  Lipoprotein‐Cholesterol Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[9]  B. Rosner,et al.  Oral Contraceptive Use and Fasting Triglyceride, Plasma Cholesterol and HDL Cholesterol , 1979, Circulation.

[10]  L. Wilkins Plasma Lipid Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study THE LIPID RESEARCH CLINICS PROGRAM EPIDEMIOLOGY COMMITTEE , 1979, Circulation.

[11]  E. Barrett-Connor,et al.  ALTERED PLASMA LIPID AND LIPOPROTEIN LEVELS ASSOCIATED WITH ORAL CONTRACEPTIVE AND ŒSTROGEN USE Report from the Medications Working Group of the Lipid Research Clinics Program , 1979, The Lancet.

[12]  I. Godsland,et al.  COMPARISON OF EFFECTS OF DIFFERENT COMBINED ORAL-CONTRACEPTIVE FORMULATIONS ON CARBOHYDRATE AND LIPID METABOLISM , 1979, The Lancet.

[13]  L. Wallentin,et al.  EFFECTS OF THREE DIFFERENT COMBINATIONS OF ETHINYL ESTRADIOL AND LEVONORGESTREL ON PLASMA LIPIDS AND HIGH DENSITY LIPOPROTEINS , 1979, Acta obstetricia et gynecologica Scandinavica. Supplement.

[14]  D. Kleinbaum,et al.  Applied Regression Analysis and Other Multivariate Methods , 1978 .

[15]  R. Krauss,et al.  Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. , 1978, The New England journal of medicine.

[16]  R. Krauss,et al.  Changes in serum high density lipoproteins in women on oral contraceptive drugs. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[17]  R. Wallace,et al.  ALTERED PLASMA-LIPIDS ASSOCIATED WITH ORAL CONTRACEPTIVE OR ŒSTROGEN CONSUMPTION The Lipid Research Clinic Program , 1977, The Lancet.

[18]  P. Steiner,et al.  Plasma high-density lipoprotein cholesterol concentrations determined after removal of other lipoproteins by heparin/manganese precipitation or by ultracentrifugation. , 1976, Clinical chemistry.

[19]  M. Thorogood,et al.  Oral contraceptive use in older women and fatal myocardial infarction. , 1976, British medical journal.

[20]  R. Edgren,et al.  Potencies of oral contraceptives. , 1976, American journal of obstetrics and gynecology.

[21]  Dickey Rp,et al.  Progestational potency of oral contraceptives. , 1976 .

[22]  C. Glueck,et al.  Effects of estrogenic compounds on triglyceride kinetics. , 1975, Metabolism: clinical and experimental.

[23]  U. Donde,et al.  The effect of combination and low dose progestogen oral contraceptives on serum lipids. , 1975, Fertility and sterility.

[24]  R. Dickey,et al.  Estrogen potency of oral contraceptive pills. , 1975, American journal of obstetrics and gynecology.

[25]  D. Mishell Current status of contraceptive steroids and the intrauterine device. , 1974, Clinical obstetrics and gynecology.

[26]  F. Davidoff,et al.  Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. , 1973, The New England journal of medicine.

[27]  A. Svanborg,et al.  Gonadal steroid effects on plasma lipoproteins and individual phospholipids. , 1972, The Journal of clinical endocrinology and metabolism.

[28]  V. Wynn,et al.  Fasting serum triglyceride, cholesterol, and lipoprotein levels during oral-contraceptive therapy. , 1969, Lancet.

[29]  W. Hazzard,et al.  Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives. , 1969, The New England journal of medicine.

[30]  H. Barber,et al.  Are the pills safe , 1969 .

[31]  O. J. Dunn Multiple Comparisons Using Rank Sums , 1964 .